What Is Nuvation Bio Inc. (NUVB) Worth in 2026?
According to the CirclFi Deep Alpha Valuation Engine, Nuvation Bio Inc.'s intrinsic value is estimated at $1.33, suggesting the stock is overvalued at its current price of $5.89. With 10 out of 11 models flagging downside (-77.3% average return), the market may be pricing in unsustainable growth. The most optimistic model, PWERM, places fair value at $5.60 (-4.9%), while ML-RIV — the most conservative — estimates $0.07 (-98.9%). This +94.0% gap reflects genuine analytical uncertainty about Nuvation Bio Inc.'s intrinsic worth.
What Do the Models Say About NUVB?
11 of 13 models are currently active for NUVB. All 11 active models suggest the stock trades above fair value. The Bayesian DCF estimates NUVB's intrinsic value at $1.46, implying -75.2% downside from the current price. See which stocks rank higher →
How Does NUVB Rank in Pharmaceutical Preparations?
Among 431 Pharmaceutical Preparations stocks, NUVB ranks #133 by Quality of Company score. CirclFi's QOC score of 5.9/10 evaluates 32 fundamental signals. A score of 5.9 reflects mixed fundamentals.
See all Most Undervalued Pharmaceutical Preparations Stocks →
As a pharmaceutical industry, Nuvation Bio Inc. operates in a sector where FDA approval probability is a critical driver of valuation. Investors evaluating NUVB should weigh these sector-specific dynamics alongside our model-derived fair values.
Is NUVB a Value Trap?
CirclFi's Value Trap algorithm assigns NUVB a score of 18/100 (SAFE). This indicates minimal risk. Fundamentals are healthy. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →
Multi-Model Methodology
11 of 13 models are active for Nuvation Bio Inc.. Broad coverage provides high confidence. Each model applies a fundamentally different valuation philosophy. See the complete methodology →
According to the CirclFi 32-factor quality framework, Nuvation Bio Inc.'s fundamental quality profile registers 5.9/10. This respectable score captures the company's profitability depth, growth consistency, balance sheet resilience, and shareholder return track record.
The gap between the most bullish and bearish model spans +94.0% — demonstrating why single-model analysis is dangerous. Browse all stocks with 13-model coverage →
Data Sources & Confidence
Every NUVB valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →
Across NUVB's 11 active models, average confidence is 23%. Lower confidence may reflect limited history or high volatility.
CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →
Buy with Gumroad